Health ❯ Medical Research ❯ Cancer Treatment

Immunotherapy

mRNA Vaccines CAR T-cell Therapy Clinical Trials CAR-T Cell Therapy Artificial Lymph Node Viral Therapy mRNA Technology CAR-T Therapy CAR T-cells Tumor Engineering Tumor Response Surgery Antibody Engineering mRNA-based Therapies STING Inhibition Exopolysaccharides TCR Cross-Reactivity Viral Immunotherapy T Cell Therapy Oncolytic Viruses Nobel Prize Contributions T Cell Engagers Bacterial Therapy T-cell Dysfunction mRNA Therapy mRNA Therapies

Moderna and Merck Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

A successful late‑stage readout may clear the way for regulatory filings while full efficacy numbers, survival data and manufacturing plans are still pending.

New CAR-T Designs Deliver Low-Dose Remissions and Expose a Senescence Risk

Waterloo Scientists Ready Engineered Tumor‑Eating Bacteria for Preclinical Testing

mRNA COVID Vaccines Tied to Longer Survival With Checkpoint Immunotherapy, Nature Study Reports

Nature Papers Identify RHOG and CDKN1B as In Vivo Boosters for CAR T Cells

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

Deep-Sea Bacterial Molecule Triggers Pyroptosis to Suppress Tumor Growth

UF Researchers Develop Universal mRNA Vaccine That Primes Immune System Against Tumors

Human-Specific STING Inhibitors Block Oligomerization Ahead of Clinical Evaluation

Leukemia-on-a-Chip Enables Rapid, Scalable CAR T-Cell Therapy Screening

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy